middle.news
Neurizon Secures $17.5 Million Non-Dilutive R&D Financing Facility
3:21pm on Friday 31st of July, 2026 AEST
•
Biotechnology
Read Story
Neurizon Secures $17.5 Million Non-Dilutive R&D Financing Facility
3:21pm on Friday 31st of July, 2026 AEST
Key Points
Up to $17.5 million facility secured against R&D Tax Incentive refunds
Initial $8 million drawdown expected post-execution
Non-dilutive funding supports HEALEY ALS Platform Trial
Facility includes extension options for FY2027 and FY2028 claims
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE